LIVANOVA PLC (LIVN) Stock Fundamental Analysis
NASDAQ:LIVN - GB00BYMT0J19 - Common Stock
56.37 USD
+0.92 (+1.66%)
56.37 USD
0 (0%)
LIVN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 190 industry peers in the Health Care Equipment & Supplies industry. LIVN has only an average score on both its financial health and profitability. LIVN scores decently on growth, while it is valued quite cheap. This could make an interesting combination.
1. Profitability
1.1 Basic Checks
In the past year LIVN was profitable.
LIVN had a positive operating cash flow in the past year.
In multiple years LIVN reported negative net income over the last 5 years.
Of the past 5 years LIVN 4 years had a positive operating cash flow.
1.2 Ratios
With a decent Return On Assets value of -8.43%, LIVN is doing good in the industry, outperforming 63.68% of the companies in the same industry.
LIVN has a better Return On Equity (-18.82%) than 61.05% of its industry peers.
The Return On Invested Capital of LIVN (8.04%) is better than 86.84% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for LIVN is significantly below the industry average of 8.46%.
The last Return On Invested Capital (8.04%) for LIVN is above the 3 year average (3.45%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.43% | ||
| ROE | -18.82% | ||
| ROIC | 8.04% |
ROA(3y)-0.17%
ROA(5y)-4.24%
ROE(3y)-0.33%
ROE(5y)-8.58%
ROIC(3y)3.45%
ROIC(5y)N/A
1.3 Margins
LIVN's Operating Margin of 14.41% is amongst the best of the industry. LIVN outperforms 83.68% of its industry peers.
LIVN's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 69.07%, LIVN is in the better half of the industry, outperforming 76.84% of the companies in the same industry.
LIVN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.41% | ||
| PM (TTM) | N/A | ||
| GM | 69.07% |
OM growth 3Y41.76%
OM growth 5Y18.95%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.63%
GM growth 5Y0.8%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LIVN is destroying value.
LIVN has more shares outstanding than it did 1 year ago.
LIVN has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, LIVN has a worse debt to assets ratio.
2.2 Solvency
LIVN has an Altman-Z score of 1.55. This is a bad value and indicates that LIVN is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.55, LIVN is in line with its industry, outperforming 57.37% of the companies in the same industry.
LIVN has a debt to FCF ratio of 2.66. This is a good value and a sign of high solvency as LIVN would need 2.66 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.66, LIVN belongs to the top of the industry, outperforming 87.89% of the companies in the same industry.
LIVN has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
LIVN has a Debt to Equity ratio (0.31) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 2.66 | ||
| Altman-Z | 1.55 |
ROIC/WACC0.95
WACC8.47%
2.3 Liquidity
LIVN has a Current Ratio of 1.29. This is a normal value and indicates that LIVN is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of LIVN (1.29) is worse than 78.95% of its industry peers.
A Quick Ratio of 1.09 indicates that LIVN should not have too much problems paying its short term obligations.
The Quick ratio of LIVN (1.09) is worse than 73.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.09 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 11.66% over the past year.
LIVN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.82% yearly.
The Revenue has grown by 8.23% in the past year. This is quite good.
LIVN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.94% yearly.
EPS 1Y (TTM)11.66%
EPS 3Y16.71%
EPS 5Y1.82%
EPS Q2Q%12.9%
Revenue 1Y (TTM)8.23%
Revenue growth 3Y6.58%
Revenue growth 5Y2.94%
Sales Q2Q%10.64%
3.2 Future
The Earnings Per Share is expected to grow by 11.46% on average over the next years. This is quite good.
Based on estimates for the next years, LIVN will show a small growth in Revenue. The Revenue will grow by 5.61% on average per year.
EPS Next Y13.43%
EPS Next 2Y11.28%
EPS Next 3Y10.28%
EPS Next 5Y11.46%
Revenue Next Year9.76%
Revenue Next 2Y8.16%
Revenue Next 3Y7.43%
Revenue Next 5Y5.61%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 15.49, which indicates a correct valuation of LIVN.
Based on the Price/Earnings ratio, LIVN is valued cheaper than 87.37% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.13, LIVN is valued a bit cheaper.
The Price/Forward Earnings ratio is 13.51, which indicates a correct valuation of LIVN.
LIVN's Price/Forward Earnings ratio is rather cheap when compared to the industry. LIVN is cheaper than 88.42% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of LIVN to the average of the S&P500 Index (22.76), we can say LIVN is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.49 | ||
| Fwd PE | 13.51 |
4.2 Price Multiples
84.74% of the companies in the same industry are more expensive than LIVN, based on the Enterprise Value to EBITDA ratio.
87.89% of the companies in the same industry are more expensive than LIVN, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.99 | ||
| EV/EBITDA | 12.57 |
4.3 Compensation for Growth
LIVN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of LIVN may justify a higher PE ratio.
PEG (NY)1.15
PEG (5Y)8.53
EPS Next 2Y11.28%
EPS Next 3Y10.28%
5. Dividend
5.1 Amount
LIVN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
56.37
+0.92 (+1.66%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners103.23%
Inst Owner Change-0.34%
Ins Owners0.28%
Ins Owner Change6.23%
Market Cap3.08B
Analysts83.75
Price Target64.9 (15.13%)
Short Float %4.19%
Short Ratio3.37
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.73%
Min EPS beat(2)13.16%
Max EPS beat(2)20.31%
EPS beat(4)3
Avg EPS beat(4)13.91%
Min EPS beat(4)-0.89%
Max EPS beat(4)23.08%
EPS beat(8)7
Avg EPS beat(8)17.82%
EPS beat(12)11
Avg EPS beat(12)17.01%
EPS beat(16)14
Avg EPS beat(16)16.29%
Revenue beat(2)2
Avg Revenue beat(2)3.38%
Min Revenue beat(2)2.76%
Max Revenue beat(2)4.01%
Revenue beat(4)3
Avg Revenue beat(4)1.98%
Min Revenue beat(4)-2.64%
Max Revenue beat(4)4.01%
Revenue beat(8)7
Avg Revenue beat(8)2.85%
Revenue beat(12)11
Avg Revenue beat(12)3.36%
Revenue beat(16)13
Avg Revenue beat(16)2.63%
PT rev (1m)3.92%
PT rev (3m)4.89%
EPS NQ rev (1m)0.95%
EPS NQ rev (3m)-2.31%
EPS NY rev (1m)2.82%
EPS NY rev (3m)2.78%
Revenue NQ rev (1m)3.19%
Revenue NQ rev (3m)4.43%
Revenue NY rev (1m)3.03%
Revenue NY rev (3m)3.18%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.49 | ||
| Fwd PE | 13.51 | ||
| P/S | 2.35 | ||
| P/FCF | 18.99 | ||
| P/OCF | 14.21 | ||
| P/B | 2.74 | ||
| P/tB | 34.07 | ||
| EV/EBITDA | 12.57 |
EPS(TTM)3.64
EY6.46%
EPS(NY)4.17
Fwd EY7.4%
FCF(TTM)2.97
FCFY5.27%
OCF(TTM)3.97
OCFY7.04%
SpS23.98
BVpS20.56
TBVpS1.65
PEG (NY)1.15
PEG (5Y)8.53
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.43% | ||
| ROE | -18.82% | ||
| ROCE | 11.23% | ||
| ROIC | 8.04% | ||
| ROICexc | 12.44% | ||
| ROICexgc | 252.77% | ||
| OM | 14.41% | ||
| PM (TTM) | N/A | ||
| GM | 69.07% | ||
| FCFM | 12.38% |
ROA(3y)-0.17%
ROA(5y)-4.24%
ROE(3y)-0.33%
ROE(5y)-8.58%
ROIC(3y)3.45%
ROIC(5y)N/A
ROICexc(3y)4.13%
ROICexc(5y)N/A
ROICexgc(3y)10.29%
ROICexgc(5y)N/A
ROCE(3y)4.82%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y4.42%
ROICexc growth 3Y38.42%
ROICexc growth 5Y24.6%
OM growth 3Y41.76%
OM growth 5Y18.95%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.63%
GM growth 5Y0.8%
F-Score6
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 2.66 | ||
| Debt/EBITDA | 1.5 | ||
| Cap/Depr | 126.11% | ||
| Cap/Sales | 4.16% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 93.41% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.09 | ||
| Altman-Z | 1.55 |
F-Score6
WACC8.47%
ROIC/WACC0.95
Cap/Depr(3y)78.91%
Cap/Depr(5y)67.73%
Cap/Sales(3y)3.13%
Cap/Sales(5y)3.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.66%
EPS 3Y16.71%
EPS 5Y1.82%
EPS Q2Q%12.9%
EPS Next Y13.43%
EPS Next 2Y11.28%
EPS Next 3Y10.28%
EPS Next 5Y11.46%
Revenue 1Y (TTM)8.23%
Revenue growth 3Y6.58%
Revenue growth 5Y2.94%
Sales Q2Q%10.64%
Revenue Next Year9.76%
Revenue Next 2Y8.16%
Revenue Next 3Y7.43%
Revenue Next 5Y5.61%
EBIT growth 1Y77.01%
EBIT growth 3Y51.09%
EBIT growth 5Y22.46%
EBIT Next Year36.75%
EBIT Next 3Y16.24%
EBIT Next 5Y3.21%
FCF growth 1Y465.94%
FCF growth 3Y20.82%
FCF growth 5YN/A
OCF growth 1Y278.91%
OCF growth 3Y21.3%
OCF growth 5YN/A